[Federal Register Volume 86, Number 12 (Thursday, January 21, 2021)]
[Notices]
[Pages 6343-6344]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-01125]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Requests for Proposals for Insulin Reimportation and Personal 
Prescription Drug Importation

AGENCY: Department of Health and Human Services (HHS), Food and Drug 
Administration (FDA).

ACTION: Notice; requests for proposals.

-----------------------------------------------------------------------

SUMMARY: On September 24, 2020, the Department issued two requests for 
proposals for the reimportation of insulin and the personal importation 
of prescription drugs on its website. The Department is issuing this 
Notice to include a revised version of the September 24, 2020 proposals 
in the Federal Register.

DATES: Proposals submitted in response to the requests for proposals 
shall be accepted and reviewed on a rolling basis, and until further 
notice.

ADDRESSES: Responses to the requests for proposals should be submitted 
to import@hhs.gov.

FOR FURTHER INFORMATION CONTACT: Nick Uehlecke, 200 Independence Ave 
SW, Washington, DC 20201; or by email at import@hhs.gov; or by 
telephone at 1-877-696-6775.

[[Page 6344]]


SUPPLEMENTARY INFORMATION: On September 24, 2020, the Department issued 
two requests for proposals for the reimportation of insulin and the 
personal importation of prescription drugs on its website. The 
proposals were issued consistent with FDA's authorities under sections 
801 and 804 of the Food, Drug, and Cosmetic Act, 21 U.S.C. 381, 384. 
The Department is issuing this Notice to include revised versions of 
these proposals in the Federal Register.

    Dated: January 13, 2021.
Alex M. Azar II,
Secretary, Department of Health and Human Services.
[FR Doc. 2021-01125 Filed 1-19-21; 8:45 am]
BILLING CODE 4150-26-P


